Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Open Access
- 9 July 2016
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 12 (7) , 1-14
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (AU) (APP1025581, APP1067728, APP628899, APP1079351)
This publication has 44 references indexed in Scilit:
- Drug Strategies Targeting CYP51 in Neglected Tropical DiseasesChemical Reviews, 2014
- Metabolomics Guides Rational Development of a Simplified Cell Culture Medium for Drug Screening against Trypanosoma bruceiAntimicrobial Agents and Chemotherapy, 2013
- Pyrimidine Salvage in Trypanosoma brucei Bloodstream Forms and the Trypanocidal Action of Halogenated PyrimidinesMolecular Pharmacology, 2013
- Metabolomic analysis of trypanosomatid protozoaMolecular and Biochemical Parasitology, 2012
- Toward Global Metabolomics Analysis with Hydrophilic Interaction Liquid Chromatography–Mass Spectrometry: Improved Metabolite Identification by Retention Time PredictionAnalytical Chemistry, 2011
- Human African trypanosomiasisThe Lancet, 2010
- The Protozoan Inositol Phosphorylceramide SynthaseJournal of Biological Chemistry, 2006
- Complex sphingolipid synthesis in plants: characterization of inositolphosphorylceramide synthase activity in bean microsomesArchives of Biochemistry and Biophysics, 2003
- Succinate Secreted by Trypanosoma brucei Is Produced by a Novel and Unique Glycosomal Enzyme, NADH-dependent Fumarate ReductaseJournal of Biological Chemistry, 2002
- Transporters in African trypanosomes: role in drug action and resistanceInternational Journal for Parasitology, 2001